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Abstract
Background:  Mismatched oligonucleotides are widely used on microarrays to differentiate
specific from nonspecific hybridization. While many experiments rely on such oligos, the
hybridization behavior of various degrees of mismatch (MM) structure has not been extensively
studied. Here, we present the results of two large-scale microarray experiments on S. cerevisiae
and H. sapiens genomic DNA, to explore MM oligonucleotide behavior with real sample mixtures
under tiling-array conditions.
Results: We examined all possible nucleotide substitutions at the central position of 36-nucleotide
probes, and found that nonspecific binding by MM oligos depends upon the individual nucleotide
substitutions they incorporate: C→A, C→G and T→A (yielding purine-purine mispairs) are most
disruptive, whereas A→X were least disruptive. We also quantify a marked GC skew effect:
substitutions raising probe GC content exhibit higher intensity (and vice versa). This skew is small
in highly-expressed regions (± 0.5% of total intensity range) and large (± 2% or more) elsewhere.
Multiple mismatches per oligo are largely additive in effect: each MM added in a distributed fashion
causes an additional 21% intensity drop relative to PM, three-fold more disruptive than adding
adjacent mispairs (7% drop per MM).
Conclusion: We investigate several parameters for oligonucleotide design, including the effects of
each central nucleotide substitution on array signal intensity and of multiple MM per oligo. To avoid
GC skew, individual substitutions should not alter probe GC content. RNA sample mixture
complexity may increase the amount of nonspecific hybridization, magnify GC skew and boost the
intensity of MM oligos at all levels.
Background
Oligonucleotide tiling arrays are a popular tool for detect-
ing transcriptionally active regions on a genomic scale.
They comprise short oligomeric probes (generally 25–70
bp) immobilized on a slide surface; a typical custom-built
tiling array today contains about 400,000 features. Tiling
arrays are distinct from traditional microarrays, which are
most often used to measure differential gene expression in
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multiple biological conditions. As such, different tech-
niques must be employed in their analysis [1].
The principle behind microarray analysis is similar to that
of traditional hybridization using nitrocellulose mem-
branes [2]: When fluorescently-labeled sample (target) is
applied to the array-bound features (probes), comple-
mentary regions of probe and target DNA will anneal to
form a stable duplex. Thus, any probe whose complemen-
tary target is present in the sample mixture should bind
fluorescent label.
However, observed fluorescent intensity (signal) can
derive not only from such gene-specific binding, but also
from non-specific binding. This occurs when target DNA
anneals in a nonspecific manner to the probe. Non-spe-
cific binding is dependent upon probe sequence, but
independent of the amount of its true target in the sample;
thus, it is unrelated to the transcriptional activity or
expression level of the gene it is designed to assay.
Controlling for such background hybridization is an
ongoing concern in microarray studies, and particularly
important for tiling arrays where the absolute intensity (as
opposed to relative intensity of two samples) is sought
and where less discretion is allowed in probe selection.
Traditional microarrays typically include only a handful
of probes per gene, which can be carefully chosen to opti-
mize binding and target discrimination. In tiling arrays
however, such probe choice is impossible, and as such
mismatch (MM) probes become an important tool to
enhance probe performance.
MM are often included on microarrays to differentiate
specific from nonspecific hybridization. The rationale for
their inclusion relies on three assumptions: first, that non-
specific binding affects perfect match (PM) and MM
probes equally; second, that the mismatch reduces the
affinity of gene-specific binding to the MM; and third, that
fluorescence signal per bound transcript is identical for
PM and MM [3]. In Affymetrix GeneChips® for example,
the central base of a 25 mer probe is replaced by its com-
plement; subtracting MM signal from PM intensity (PM-
MM) is meant to yield true probe signal corrected for non-
specific background. However, MM signal is often greater
than PM signal [4] and either ignored entirely [5,6] or
simply used to exclude outliers.
All nucleotide substitutions do not have an equal impact
on hybridization efficiency. Previous work has explored
these differences in solution [7] and in silico [8] using
solution-phase algorithms, but solution-phase kinetics do
not translate well to solid phase hybridization [9].
While many experiments include probes with single MMs,
and much previous work has focused on trying to model
hybridization on microarrays [3,9], the hybridization
behavior of various degrees of MM structure on arrays
remains poorly understood. More elaborate mismatch
strategies for oligonucleotide microarrays have been
investigated in the context of resequencing and muta-
tional analysis [10]. Moreover, experiments examining
MM behavior on arrays often rely on spike-in [11] or cus-
tom synthesized sample mixtures [7,12], which limit non-
specific hybridization and differ from the complex mix-
tures normally present in array experiments.
In array design, a great deal of work has focused on select-
ing the best probes from genomic DNA. Several software
programs exist to design oligos for microarrays: CommO-
ligo [13], ArrayOligoSelector http://sourceforge.net/
projects/arrayoligosel/, OligoArray [14], OligoArray 2.0
[15], and OligoPicker [16]. Factors considered include
maximizing probe uniqueness in the genome to minimize
cross-hybridization, and altering probe length to conform
to a needed range of melting temperature. Little thought
is given to selecting nucleic acid substitutions for MM
probes; typically, the PM middle base's complement is
chosen, without consideration for the potential differ-
ences in signal that can arise from these choices.
The behavior of multiple MM per probe has not been
deeply explored. In 2003, DiRisi and coworkers examined
the effects of multiple MM on 70 mer probes arranged
according to two schemes: internal (distributed at random
along the length of the probe), and anchored (contiguous
at either end) [17]. While the relative intensity in the
anchored MM set decreased gradually as more MM were
added, the internal MM set disrupted hybridization much
more efficiently and fell off too rapidly to extract the cost
per MM.
Here, we present the results of two large-scale microarray
experiments to explore MM oligonucleotide behavior with
real sample mixtures under tiling-array conditions. We
designed two microarrays to assess the performance of MM
oligonucleotides, one design using the Baker's yeast Saccha-
romyces cerevisiae (probed with total RNA), and the other
design using human genomic material (probed with placen-
tal RNA). MM probes were selected from a set of fourteen
designs. These include three SingleCenter designs (center
position 18 of each 36-mer changed to all three possible sub-
stitute nucleotides), five centered designs (3, 5, 7, 9, and 11
MMs arranged about the center position in a contiguous
group), five staggered designs (2, 3, 4, 5 and 7 MMs distrib-
uted evenly throughout the 36-mer) and one deletion of the
central position. Experiments were carried out in triplicate,
and the data has been deposited in the GEO database (GEO
accession GSE13175).
The yeast array includes a 10 kb region surrounding the
highly-expressed ACT1 gene, tiled double-stranded withBMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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36-mer probes at 1 bp spacing. For each PM oligo derived
from this gene's sequence, all fourteen MM oligos designs
were included. The yeast array also includes six additional
genes, tiled single-stranded with 36-mer probes at 1 bp
spacing, with a smaller set of four MM oligos per PM. The
human array includes three RefSeq genes (HBG2, TIMP3,
SYN3) with flanking regions, tiled double-stranded with
36-mer probes at 1 bp spacing (similar to ACT1, above).
Thirteen MM oligos were included for each human PM
probe (the deletion MM was not included in the human
design).
We analyze the effect of each MM substitution under real
conditions, and examine the impact of including multiple
MM in a single probe. Though there do exist some caveats
– namely, that the conclusions presented here may not
apply exactly to different array types, oligonucleotide
lengths, labeling methods and so on – these results will be
useful in computing nonspecific hybridization of individ-
ual probes, and as a general guideline for designing MM
probes for tiling arrays: a new and exciting application of
array technology, where single MM probes no longer suf-
fice.
Results
Genomic regions from seven S. cerevisiae genes and three
human genes were tiled with perfect match (PM) and mis-
match (MM) oligos, the arrays were probed and the result-
ing intensities normalized as outlined in the Methods
section.
Four distinct classes of MM oligo were employed: Single-
Center, wherein the nucleotide at the center position (18)
is changed; centered, wherein mismatch bases are added
incrementally from the center of the oligo; staggered,
wherein mismatch bases are distributed throughout the
length of the oligo; and deletion, wherein the center posi-
tion (18) is removed, and the oligo is elongated by adding
the next base in genomic sequence. The location of mis-
match bases in these designs is given in Table 1, and sche-
matized in Figure 1. The aforementioned genes were tiled
with various sets of these MM designs.
Our normalization scale equates median log intensity of
high-expression regions to 1.0, and median log intensity
of non-coding regions (background) to 0.0 (Figure 2a–d);
thus, an oligo with intensity equal to that of a highly-
expressed region will be assigned a score of ~1, while an
intensity near baseline will score ~0. MM oligos were eval-
uated by taking the difference in normalized intensities
(MM-PM). This value is expressed as a percentage of the
total intensity range. (Thus, if the normalized PM probe
intensity is 0.8, and the normalized MM intensity is 0.6,
the MM-PM difference will be -0.2 on our normalized
scale, which equates to 20% of the total normalized inten-
sity range.) Original data is available from GEO (acces-
sion GSE13175).
Single Center MMs
Behavior of each possible nucleotide substitution was
assessed with SingleCenter MM oligos. Figure 3 shows the
cost per individual replacement, assessed over all regions
tiled (seven yeast genes and three human genes).
Table 1: Mismatch designs
DESIGN # MMs MM BASE LOCATIONS
PM 0 --
Centered
c1 1 18
c3 3 17–19
c5 5 16–20
c7 7 15–21
c9 9 14–22
c11 11 13–23
Staggered
s2 2 12, 24
s3 3 12, 18, 24
s4 4 6, 12, 18, 14
s5 5 6, 12, 18, 24, 30
s7 7 6, 12, 15, 18, 21, 24, 30
Design of mismatch oligo classes: SingleCenter (c1), centered (c2-
c11) and staggered (s2-s7).
Mismatch schematic Figure 1
Mismatch schematic. Schematic of mismatch oligo design. 
Black represents mismatch positions. SingleCenter is the left-
most centered design, and comprises three distinct oligo 
designs: one for each central base substitution.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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Gene regions & mixture complexity Figure 2
Gene regions & mixture complexity. (a, b) Signal plots (blue) for yeast ACT1 (a) and human HBG2 (b) genes, showing 
annotated coding regions (green). (Flanking regions not shown.) (c, d) Intensity normalization: Representative coding (left) and 
non-coding (right) regions selected from genes (including flanking regions) and used for normalization from ACT1 (c) and 
HBG2 (d). Median intensity in coding regions was set to 1, and median intensity in non-coding regions was set to 0 (red line). 
All slide intensities were normalized to these values. (e) Mixture complexity: Normalized intensity variance for ACT1 and 
HBG2. Increased mixture complexity in human corresponds to larger signal variance, particularly in low expressed regions.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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In both species, C→A was the most disruptive change (-
11% yeast, -9% human), followed by C→G (-10% yeast, -
8% human) and T→A (-9% yeast, -6% human); G→A,
T→G and C→T were the next most disruptive changes.
The least disruptive changes were those beginning with
adenine, A→C (-2% yeast, +3% human), A→T (-3% yeast,
+1% human), and A→G (-3% yeast, no change in
human), followed by T→C, G→C, and G→T. In human,
the two least disruptive MMs actually increased median
spot intensity relative to PM. It should be emphasized that
a wide range of values was found in each case (note stand-
ard deviation bars in Figure 3). The aforementioned val-
ues are the median intensity changes.
GC skew
SingleCenter nucleotide substitutions were grouped into
equivalent mispairs as shown in Table 2. The median
intensity difference (MM-PM) vs. mispair orientation is
given in Figure 4b–e. A consistent skew is seen: nucleotide
substitutions that increase the GC content of the 36 mer
probe have a higher median intensity than those that
decrease it or leave it unchanged. This trend is seen across
all tiled regions (Figure 4a, b), in the highest intensity
spots (Figure 4c, d) and the lowest intensity spots as well
(data not shown).
The twelve individual SingleCenter nucleotide substitu-
tions were then regrouped into three classes according to
their effect on the GC content of the oligo. Overall, the
median intensity difference of a single substitution at
position 18 can vary between -4% and -8% in yeast
depending on its effect on GC content (Figure 4e). In low
expression regions, this spread remains pronounced (red
line; between 0% and -3%) whereas in highly expressed
regions, the spread is narrower (blue line; between -8%
and -9%). In human (Figure 4f) the same effect is seen.
Overall, the median intensity difference of a single center
substitution varies between 0% and -5% depending on
GC effect; in low expression regions, this range shifts
upwards (from +3% to -2%) and in highly expressed
regions the skew is lessened (-5% to -6%).
Non-specific binding due to homopolymer C nucleotide 
runs
We have found that oligonucleotides that contain consec-
utive runs of C nucleotides longer than or equal to four
Effect on probe intensity of all possible single-base substitutions Figure 3
Effect on probe intensity of all possible single-base substitutions. Median intensity difference vs. MM substitution for 
all assayed regions in yeast (a) and human (b). Green curve is median intensity difference (MM-PM) for all instances of substitu-
tions listed on the x-axis. Error bars represent ± σ for this curve. Blue curve: median intensity difference for high-intensity 
spots only (top 10% of spots by PM intensity). Red curve: median intensity difference for low-intensity spots (bottom 10% of 
spots by PM intensity).
Table 2: Table of GC skew and equivalent substitutions
Substitution T→GC →AT →CG →AA →GC →TA →CG →TC →GT →AG →CA →T
Mispair G-A A-G C-A A-C G-T T-G C-T T-C G-G A-A C-C T-T
G C  E f f e c t +-+- +-+-== ==
All possible single nucleotide substitutions, grouped into equivalent mispairs (a): base substitution (top, shown as original→substitution) leads to 
mispair (middle row) with resulting effect on GC content of oligo (bottom, + for increase in oligo GC content, - for decrease).BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
Page 6 of 14
(page number not for citation purposes)
GC skew in equivalent substitutions Figure 4
GC skew in equivalent substitutions. (a-d) Median intensity difference vs. mispair orientation for equivalent mispairs in 
yeast (a, c) and human (b, d). For each mispair, the base listed first is contained in the array-bound oligo, while the second is its 
presumed counterpart in solution. Mispairs are plotted in the order shown in Table 2. Boxes represent inter-quartile range (i.e. 
middle 50% of intensity values for each mispair lie between upper and lower bounds). Figure gives mispair skew for all assayed 
regions (a, b), and for high-intensity (c, d) spots only. (e, f) Median intensity difference vs. GC effect in yeast (e) and human (f): 
plots those substitutions which increase GC content of oligo (GC+, left side of graph), those with no effect on GC content 
(GC =, middle) and those decreasing GC content of oligo (GC-, right). (g) Absolute value of the GC skew between equivalent 
mispairs presented in (a-f), with average skew by species and subset. (h) Intensity as a function of the longest length of a 
homopolymer nucleotide run contained within the sequence of an oligonucleotide probe. A (blue), C (black), G (green) and T 
(red) are displayed. Human PM data is shown here.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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show abnormally high fluorescent intensity for the case of
the human PM data. In Figure 4h we plot the average
intensity of probes containing a homopolymer run of
nucleotides (either A, C, G or T) of a given length. We
observe that the hybridization intensities of oligonucle-
otides containing a run of four or more C's are signifi-
cantly higher than the average array signal intensity. This
effect is not simply due to these oligonucleotide probes
containing large amounts of C nucleotides: we have
observed that probes specifically with runs of four or more
C have higher intensities than oligonucleotides with the
same C nucleotide content but lacking a contiguous run of
C. We also observe that oligonucleotide probes with no A
show enriched signal intensities.
This effect does not appear to be caused by direct binding
of oligonucleotides to reverse complements by Watson-
Crick base pairing, since this effect is not present for con-
secutive runs of G's. We hypothesize that runs of C's cause
oligonucleotide probes to exhibit non-specific cross-
hybridization to targets other than their reverse comple-
ment. Potentially, this binding might be more exotic than
regular Watson-Crick base pairing. This effect has been
observed for other sets of human tiling array data, how-
ever this effect is not present for the yeast PM data. One
possible explanation for the enhanced signals from oligo-
nucleotides probes with poly-C runs is offered by Nelson
et al. in 2007 [18], in a study which identified an artifact
caused by the T7 primer used by the in vitro transcription
system that caused certain oligonucleotide probes to yield
increased signal. However, this still does not explain the
differences in poly-C intensity observed between human
and yeast arrays.
When designing tiling microarrays, care should be taken
to avoid oligonucleotide sequences containing runs of
consecutive C, since these may not probe only intended
targets and may instead yield ambiguous signals.
Deletion MMs
Deletion MMs were found to have an effect similar to Sin-
gleCenter MMs. Full results are available in supplemen-
tary material online.
Multiple MMs
For multiple MM studies, we focused on two individual
highly expressed genes, yeast ACT1 and human HBG2.
These were partitioned into exonic and intergenic regions
by annotation reference (this partitioning was supported
by observed array intensities). The median intensity dif-
ference for each MM design is given in Figure (5a, b).
In exonic regions (red), additional mismatches cause a
downward trend in intensity relative to the PM. In inter-
genic regions, mismatches show no distinct trend, but
instead fluctuate about the PM intensity.
Figure 5(c–f) shows the signal plots for centered (c, d) and
staggered (e, f) MMs in yeast and human, superimposed
on a PM trace. The regions shown are the same coding and
non-coding excerpts given in Figure 2.
Cost per additional MM
Figure 6 plots the median intensity difference for each
mismatch design relative to PM for exonic DNA in yeast
ACT1 (a) and human HBG2 (b). We computed the cost
per n MMs for each scheme by fitting each to a linear
equation, expressed in terms of normalized intensity dif-
ference  i  (MM-PM). In ACT1, the five multiple MM
designs in the centered scheme (c3, c5, c7, c9, c11) fit to i
= -0.0669n + 0.0253 with R2 = 0.995, whereas the four
staggered MM designs (s2, s3, s4, s5) fit to i = -0.2138n +
0.2108 with R2 = 0.998. In HBG2, the centered designs fit
to i = -0.0672n + 0.0902 (R2 = 0.974) and the four stag-
gered designs fit to i  = -0.2227n  + 0.2781 with (R2 =
0.997). In both species, the fifth staggered design (s7) was
excluded from the fit, since the observed linear behavior
plateaus near baseline intensity.
Extracting the slopes of these curves, we determine that
each additional mismatch in the centered scheme costs
~7% of PM intensity in both yeast and human, whereas
each mismatch added in a staggered scheme is approxi-
mately three-fold more disruptive (cost is ~21% per MM
in yeast and human).
Using MM to discern coding regions
To assess the performance of the various MM classes at
discerning transcribed sequence, a set of pair-wise t-tests
were performed. A 0.5 kb region (comprising 512 distinct
probes) was selected from within a known coding region,
and contrasted with a non-coding region of equal size. A
t-test was performed for each MM with the PM. This was
done for two genes, ACT1 (yeast) and HBG2 (human).
In known coding regions, all MMs differed significantly
from the PM (p < 1 × 10-100 in all cases). The s7 design (7
mismatched bases staggered throughout the oligo) was
the most different from PM (off scale, p = 0 in both yeast
and human). In known non-coding regions, MMs dis-
played a range of performance: some were significantly
different from PM (in particular the c11 design, p = 2 × 10-
6 in yeast, p = 3 × 10-5 in human), whereas the s7 design
was indistinguishable from PM in both cases (p = 0.21 in
yeast, p = 0.08 in human).
Because the windows for scoring transcribed fragments
are often short (5–10 probes), the above assay was
repeated with 10 probes per window. The same patternBMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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MM vs PM Figure 5
MM vs PM. (a, b) Median intensity difference (MM-PM) vs. mismatch design for yeast ACT1 (a) and human HBG2 (b) genes. 
Mismatch oligos were divided into two groups: those taken from exonic regions are shown in red; intergenic regions, shown in 
blue. (c, d) Centered MM intensities superimposed on PM for coding (left) and non-coding (right) regions. (e, f) Staggered MM 
intensities superimposed on PM for coding (left) and non-coding (right) regions.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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was observed: in a window containing known coding
sequence, all MM classes could be distinguished from PM
(p <= 1 × 10-4 in all cases), with the s7 design displaying
the smallest p-value (p = 2 × 10-9 in yeast, p = 8 × 10-11 in
human). In non-coding windows, most MM classes were
indistinguishable from PM, and again the s7 design had
the highest p-values (p = 0.72 in yeast, p = 0.37 in
human).
Discussion
Oligonucleotide probes containing single mismatch
(MM) positions are frequently included in microarrays to
control for nonspecific hybridization. Relative to the per-
fect match (PM), the mismatch oligo should exhibit much
less gene-specific binding, but a similar amount of non-
specific binding; thus, subtracting the MM signal should
yield a true PM corrected for nonspecific binding. In prac-
tice, selecting the number, type and placement of MM in
a given probe is challenging, particularly in the case of til-
ing arrays which permit far less flexibility in probe selec-
tion than traditional expression arrays. We have
conducted microarray experiments in two species to dem-
onstrate the behavior of various types of MM design under
normal experimental conditions. These results represent a
formal examination of previously unstructured and
largely anecdotal microarray knowledge, and a resource
useful for array design.
Single MMs at the central position
We demonstrate here that the amount of nonspecific
binding exhibited by MM oligos is dependent upon the
individual nucleotide substitutions they incorporate, and
therefore not necessarily equivalent to that experienced by
the PM probe – this finding undercuts a main assumption
underlying the use of MM probes. For each of the four
DNA nucleotides (A, C, G, and T) there exist three possi-
ble substitutions, and we find that these twelve possible
replacements exhibit a range of effect on MM intensity.
Some of these are anticipated: for instance, sterically unfa-
vorable purine-purine mispairs such as A·G are expected
to destabilize duplex DNA more than purine-pyrimidine
mispairs. Our findings support this, with the three purine-
purine mispairs – C→A (yielding the A·G mispair), C→G
(G·G mispair) and T→A (A·A mispair) – emerging as the
most disruptive single substitutions.
However, we are also able to revise and refine predictions
stemming from earlier work. Using in silico hybridization
models of single-point mismatches, Athey and coworkers
(2004) [8] predicted that G→X would be the substitution
most disruptive to oligonucleotide hybridization, while
A→G and T→G would be the least. We report here that in
practice, C→X is most disruptive, and the three A→X
changes are least disruptive. Zhang and coworkers
reported that although G·G is more stable than C·C in
solution, the reverse is true on an array [11]. We confirm
that the G→C substitution (C·C mispair) is more stable
than the C→G substitution (G·G mispair), further sup-
porting the notion that solution-phase values do not nec-
essarily translate to solid-phase hybridization [9].
These results are worthwhile to consider when making
single MM changes, particularly when the position to be
substituted is C (greatest effect) or A (smallest effect).
GC skew effect
A notable contribution to the spread of intensities from
single-point mismatches is a phenomenon we term the
Intensity change per mismatch Figure 6
Intensity change per mismatch. Intensity change per added mismatch in exonic region of yeast ACT1 (a) and human HBG2 
(b). Error bars represent ± σ.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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GC skew effect. With the exception of homogeneous mis-
pairs (C·C, G·G, A·A and T·T), any given non-Watson-
Crick mispair can be produced via two distinct mismatch
substitutions (e.g., C→A and T→G both yield the A·G
mispair). We term these pairs of changes equivalent substi-
tutions. In the absence of nonspecific binding, cross-
hybridization, or other array effects, such equivalent sub-
stitutions should yield equivalent spot intensity: an A·G
mispair, no matter which (the A or the G) was introduced
as a MM, should disrupt binding consistently. Thus, by
examining the intensity differences between equivalent
substitutions in aggregate, we can quantify the contribu-
tion of factors other than specific binding to observed
oligo intensity.
To illustrate this phenomenon, single-point nucleotide
substitutions are grouped into dyads, each representing an
equivalent substitution. What emerges is a consistent
skew, which can be stated as follows: All else equal, any
substitution that elevates probe GC content will exhibit
higher intensity, whereas any substitution that lowers
probe GC content will decrease intensity.
We expect the GC skew effect to be more pronounced
both in low-expressed regions – where nonspecific bind-
ing is a large component of total signal intensity – and in
experiments where high mixture complexity of sample
RNA provides increased potential for nonspecific hybridi-
zation, such as human arrays. We indeed find that in
highly-expressed regions the average GC skew is small
(±~0.5%) and similar in both human and yeast; but in
low-expressed regions the average skew is markedly larger
in yeast (±~1.5%) and larger still (±~2.2%) in human.
GC skew likely stems from a combination the increased
'stickiness' of the triple-H-bond arrangement of G and C
nucleotides, combined with mixture complexity. (Sample
labeling is likely not a contributing factor to GC skew,
because on tiling arrays end-labelling is frequently used.)
A complex sample RNA mixture will offer ample substrate
for nonspecific hybridization.
It is evident that GC skew can constitute a large compo-
nent of the effect of any single mismatch. Therefore, if
employing mismatches to control for nonspecific hybrid-
ization, one should take care to make substitutions that
do not alter the GC content relative to the PM oligonucle-
otide. That is, individual bases should be substituted with
their Watson-Crick complements (A→T, C→G, G→C,
T→A). This is the substitution matrix employed by
Affymetrix for GeneChip® arrays. It should be noted that
while insulated from GC bias, these substitutions do
nonetheless exhibit differing effects on intensity: in yeast,
the maximal intensity spread between C→G (G·G mis-
pair) and A→T (T·T mispair) is ~7%; in human, it can
reach ~9%.
Companies such as Affymetrix® have for some time insu-
lated single-MM probes from GC bias in this manner.
However, the full formalism for why and how this matrix
is effective has not previously been reported in the litera-
ture. We demonstrate here why this approach is valuable
and should be replicated where possible when construct-
ing multiple-MM oligos. (A skew does remain, however,
in the relative intensities of MM oligos depending upon
the original nucleotide at the substituted position, as
stated in the previous section.)
Multiple MMs
In addition to all possible single-point substitutions at the
center position, we also assayed ten MM oligo designs
with multiple mismatches arranged in two schemes: cen-
tered and staggered. We report here that on the normal-
ized log scale used in this work, both schemes conform to
a fundamentally linear decay of signal, suggesting that
multiple mismatches display a largely additive effect.
Because efficient duplex hybridization requires an unin-
terrupted run of complementary nucleotides, we expect
the staggered scheme to be most disruptive [12,17]. This
is evident in the results: each additional staggered MM
causes > 20% intensity drop, whereas each centered MM
causes only 7% intensity drop. The staggered curve is lin-
ear (R2 = 0.998 yeast, R2 = 0.997 human) from 2 through
5 mismatches, and diverges at the 7 MM level. This behav-
ior is in line with expectation: oligonucleotides with the
maximum possible number of mismatches (i.e. with every
position changed) would share no sequence in common
with the PM and should, on average, display signal in line
with slide background intensity – the signal displayed by
DNA regions that are not transcribed and thus should not
be present in the target mixture. Thus, the theoretical
lower bound intensity for unlimited mismatches is the
slide background intensity, equivalent to 0 on our nor-
malized log scale. In reality this lower bound is reached
quite early: with 7 staggered mismatches, the signal has
already diverged from the linear progression. For centered
MM, by extrapolating the linear fit we predict that this
scheme should begin to plateau around 15 MM per 36-
mer probe; after which point additional MM should no
longer reliably affect hybridization signal intensity.
Although signal decay from centered mismatches is linear
to a good approximation, a slight synergistic effect is seen:
Centered MM progressions in both yeast and human devi-
ate somewhat from true linearity, suggesting some coop-
erativity between multiple mismatches in this scheme
(this effect is more pronounced in human). This agrees
with an earlier study, which suggests a synergistic effectBMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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between multiple mismatches [8]. This is understandable
since centered MMs are introduced adjacent to one
another, creating a contiguous run of MMs whose effect
may be slightly more than the sum of its parts. In contrast,
staggered MMs are introduced in isolated locations, and
display near-perfect linear decay, suggesting a lack of
cooperativity in this scheme.
The intercepts of the fit lines for the centered MM scheme
provide an interesting insight into nonspecific hybridiza-
tion behavior. In yeast and human, these lines have the
same slope (7% normalized intensity decrease per mis-
match), but extrapolating back to n = 0 MMs yields an
intensity higher than that of the true PM in either case.
This suggests that MM oligos pick up more signal than
they should due to nonspecific hybridization, and that the
amount of this signal boost is consistent at each n. The
amount of this signal boost is encapsulated in the y-inter-
cept value: These are different in yeast (+2.5%) and
human (+9.0%), suggesting a differing amount of non-
specific hybridization is contributing in each case. The
increased RNA sample complexity in human may account
for the higher signal boost observed at every MM level.
In intergenic (noncoding) regions, staggered mismatches
show no distinct progression, but instead fluctuate about
the baseline intensity. This is in line with expectation: in
non-transcribed regions, deviation from the PM oligo
should be no more or less likely, on average, to base-pair
with material in the RNA sample mixture. The centered
scheme however displays a slight upward intensity trend
in intergenic regions. This cannot be explained by GC
skew or general nonspecific binding, and presents an
interesting matter for further inquiry.
Identifying transcribed regions: Which MM is best?
A typical goal when employing MM oligos on an array is
to help distinguish transcribed from untranscribed
regions. A good MM design will thus yield intensities sig-
nificantly different from PM in transcribed regions, and
close to or indistinguishable from PM in untranscribed
areas. We assessed the behavior of the various MM classes
with respect to this task, and found that while all MM
classes could be distinguished from PM in short (10 oligo)
or long (512 oligo) windows of known coding sequence,
their performance in non-coding windows varied. The s7
design (7 mismatched bases staggered throughout the
oligo) performed best in both human and yeast: its p-
value was smallest (i.e., most distinguishable from PM)
across known coding sequence, and largest (i.e., least dis-
tinguishable from PM) in non-coding sequence. If gener-
ally applicable, this result suggests that a design bearing
multiple staggered mismatches should outperform the
traditional single-center mismatch oligos in current use,
with respect to discerning transcribed sequence.
This is true in aggregate, but what about taking each oligo
on its own? In aggregate, MM are not needed, since
instead randomized oligos could be put down to yield
background signal which could then be subtracted out.
This however does not preserve the (nonspecific) binding
characteristics of the PM, which is the idea underlying the
MM.
Conclusion
We have conducted two large-scale microarray experi-
ments to explore mismatch oligonucleotide behavior with
real sample mixtures under tiling-array conditions. We
show that the amount of nonspecific binding by MM oli-
gos is dependent upon the individual nucleotide substitu-
tions they incorporate: C→A, C→G and T→A (all yielding
purine-purine mispairs) were most disruptive, whereas
A→X changes had the least disruptive effect.
We also characterize a marked GC skew effect: All else
equal, any substitution that raises probe GC content will
exhibit higher intensity, whereas an equivalent change
that lowers GC content will decrease intensity. This effect
is most pronounced in mid- to low-expression regions,
where nonspecific hybridization plays a larger role in total
signal intensity. To prevent this skew, substitutions
should be made that do not affect the GC content relative
to the PM oligo (i.e., A→T, C→G, G→C, and T→A).
Multiple mismatches are largely additive in effect: both
schemes (centered and staggered) conform to a near-lin-
ear decay of signal, although staggered MM are three-fold
more disruptive. Each staggered MM causes > 20% inten-
sity drop, compared with 7% per centered MM. Centered
MM also display slight cooperativity, likely owing to their
adjacent positioning.
RNA sample mixture complexity may affect MM binding
by increasing the amount of nonspecific hybridization,
thereby magnifying the GC skew and boosting the inten-
sity of MM oligos at all levels. It does not, however, appear
to affect the cost per incremental MM in either scheme.
The increased mixture complexity in human is visible in
increased intensity variance, particularly in non-coding
regions.
These guidelines should prove useful in designing MM
oligonucleotides for tiling array experiments.
Methods
Yeast and human genomic sequence
Yeast gene sequence coordinates were accessed via SGD
ftp://ftp.yeastgenome.org/yeast/ and human genic coordi-
nates via UCSC genome browser [19]. For human
sequence, repeat regions were masked out by selecting the
UCSC repeat masking option on sequence retrieval.BMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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Yeast tiling and MM oligos
For S. cerevisiae, genomic regions were tiled as follows. A
10 kb double-stranded region centered around the
YFL039C/ACT1 gene (chromosome 6, coordinates
48,796–59,195, 10,400 bp), was tiled with 36 mer oligos
spaced every 1 bp, along with a full complement of 14
MMs (3 single-center, 5 staggered and 5 centered mis-
match oligos, and one deletion oligo) per PM oligo, with
PM synthesized in duplicate; then, six other genes each
including +/- ~500 bp flanking regions (YBL092W/
RPL32, chr2: 45,475–46,832 = 1357 bp; YGR155W/CYS4,
chr7: 798,046–800,534 = 2488 bp; YOL040C/RPS15,
chr15: 254,075-252,682 = 1395 bp; YOR312C/RPL20B,
chr15: 901676-899780 = 1898 bp; YMR242C/RPL20A,
chr13: 754,696-752,759 = 1939 bp; YLR229C/CDC42,
chr12: 605,289-603,749 = 1542 bp), were tiled with 36
mer oligos spaced every 1 bp, coding strand only, PM
included once, along with a smaller complement of four
MMs (three single-center oligos and one deletion oligo)
per PM oligo.
The total oligo count for the ACT1+flank region was
10,400 bp × 2 (double stranded) × 2 (PM in duplicate) =
41,600 PM oligos, plus 14 MM oligos per PM = 291,200
MM oligos, to yield 332,800 oligos total. For the six genes
tiled single-stranded, the total oligo count was 1357 +
2488 + 1395 + 1989 + 1939 + 1542 = 10,710 PM oligos
plus 4 MM oligos per PM = 42,840 MM oligos, to yield
53,550 oligos total. The total oligo count on the slide was
thus 332,800+53,550 = 386,350. This slide was produced
and assayed in triplicate.
Human tiling and MM oligos
For human, genomic regions were tiled as follows. Dou-
ble-stranded regions flanking exons of three main RefSeq
genes (HBG2, TIMP3, SYN3) with masked repeats
excluded in each case: HBG2 with 500 bp upstream and
500 bp downstream, 2464 bp total; TIMP3 first exon with
499 bp upstream and 500 bp downstream, 1722 bp total;
TIMP3 last two exons with 978 bp upstream and 500 bp
downstream, 5810 bp total; SYN3 first exon with 312 bp
upstream and 300 bp downstream, 531 bp total; SYN3
second exon with 363 bp upstream and 502 bp down-
stream, 907 bp total. These regions were tiled with 36
mers spaced at 1 bp, with PM in duplicate and 13 MMs (3
single-center, 5 staggered and 5 centered mismatch oli-
gos) per PM oligo were included. The total count for these
regions was 11,434 bp × double stranded × PM in dupli-
cate = 45,736 PM oligos, plus 13 × 22,868 = 297,284 MM
oligos for a total count of 343,020. Then, two additional
gene regions were tiled, also as 36 mers spaced at 1 bp,
coding strand only, PM once and no MMs. These regions
were: FLNA (entire gene region including introns, repeat
regions removed + 1000 bp upstream and 1000 bp down-
stream = 25,108 oligos), FBXO7 (entire gene region
including introns, repeat regions removed + 500 bp
upstream and 500 bp downstream = 16,635 oligos. The
total oligo count on the slide was thus 343,020 + 25,108
+ 16,635 = 384,763 oligos. This slide was produced and
assayed in triplicate.
Normalization
The six slides (3 identical yeast slides and 3 identical
human slides) were normalized by setting the 1.0 and 0.0
values to the median intensity in known highly expressed
and lowly expressed regions, respectively, then assessing
each additional intensity as a fractional value on this
scale. In all cases, raw intensity values were converted to
log (base 2) intensity values before this normalization
process. The pairwise correlation coefficient matrices of
each three-slide set (three slides each for yeast and
human) were computed and showed very strong agree-
ment (0.99+ for all pairs, data not shown).
For yeast, the upper limit was set with a 1 kb region
selected from the main ACT1 exonic region (chr6: 54,387-
53,388), and the lower limit was set with a 1 kb region
selected from low-expression intergenic region near ACT1
(chr6: 49795-48796). The median intensities for both
these regions were recorded for each of three slides, and
the normalized intensity was obtained from raw intensity
by subtracting the lower bound, and dividing by the dif-
ference of upper and lower bounds. Thus, for the three
yeast slides (internal identifier numbers 46881, 47199
and 47202), the formulae were: slide 46881, (intensity-
7.51)/6.65; slide 47199, (intensity-7.79)/6.62; slide
47202, (intensity-8.04)/6.58. Because the median high
and low values were selected as bounds, some oligos have
normalized intensity > 1 or < 0. The normalized PM inten-
sity ranged from -0.281 (min) to 1.226 (max) with 70.2%
of oligos falling in the range 0–1.
For human, the upper limit was set with a 0.5 kb region
consisting of all HBG2 exonic regions (chr11: 5240320-
5240201, 5240053-5239855 and 5238944-5238755)
and the lower limit was set with the 1.8 kb intergenic bal-
ance of the HBG2 region (chr11: 5240820-5240346,
5240175-5240079, 5239829-5238970, 5238729-
5238266). Normalized intensity was obtained as above.
For the three human slides (internal identifier numbers
43854, 46247 and 46254), the formulae were: slide
43854, (intensity-8.19)/6.53; slide 46247, (intensity-
7.69)/6.69; slide 46254, (intensity-7.66)/6.97. The nor-
malized PM intensity ranged from -0.324 (min) to 1.195
(max) with 79.7% of oligos falling in the range 0–1.
Arrays and hybridization
Arrays were designed using purpose-written Perl scripts
and created by Nimblegen, and probed with yeast poly-ABMC Genomics 2008, 9:635 http://www.biomedcentral.com/1471-2164/9/635
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RNA and human placental RNA as per established meth-
ods [20,21].
Media and growth conditions
Yeast strain BY4741 (leu2Δ0 ura3Δ0 met15Δ0 his3Δ1)
was grown at 30C to mid-exponential phase (OD 600 =
1.0) in YPAD rich medium.
RNA preparation
Total RNA was extracted from Ribopure Yeast kit
(Ambion, Austin, TX) and treated for 30 min at 37°C with
RNAse free DNase I (Ambion). Human placental poly
(A)+ RNA pooled from 2–3 individuals was purchased
from Ambion (Austin, TX).
Preparation of labeled c-RNA targets
The labeling was performed using Eberwine procedure to
amplify the starting material. RNA was converted to dou-
ble stranded cDNA using Gibco BRL(Rockville, MD)
superscript choice system and an oligo (dT) primer con-
taining the T7 RNA polymerase promoter (Proligo LLC)
[5'GGCCAGTGAATTGTAATACGACTCACTATAGGGAG-
GCGG(dT)24-3']. Briefly, 10 μg total RNA or 2 μg
poly(A)+ RNA was incubated with 5× first strand buffer,
0.1 M DTT, 10 mM each dNTPs, 5 pmol primer for 60
minutes at 42°C. Second strand synthesis was accom-
plished by incubation with 40U DNA polymerase I, 2U of
Escherichia coli RNase H, 10 mM ea dNTPs and 10U of
Escherichia coli DNA ligase in 5× second strand buffer for
2 hours at 16°C. The double strand cDNA synthesis was
terminated by incubating with 10U of T4 DNA polymerase
for 5 minutes at 16°C. Double stranded cDNA was puri-
fied using phenol chloroform extraction and ethanol pre-
cipitated, washed with 80% ethanol and resuspended in
3.25 μL of water. Invitrotranscription (IVT) was used to
produce biotin labeled cRNA from the cDNA using the
Ambion (Austin, TX) MEGA script T7 kit. Briefly, 1 μg dou-
ble stranded cDNA was incubated with 7.5 mM ATP and
GTP, 5.625 mM CTP and UTP and 1.875 mM bio-11-CTP
and bio-16-UTP (Enzo or Perkin Elmer) in 1× transcrip-
tion buffer and 1× T7 enzyme mix at 37°C for 5 hours. Inv-
itrotranscribed biotin labeled cRNA was purified on
RNeasy mini columns (Qiagen) according to manufac-
turer's protocol. cRNA was quantified by absorbance at
260 nm.
Microarray hybridization and washing
Before hybridization, cRNA was fragmented to an average
size of 50–200 bp by incubating in 5× RNA fragmentation
buffer (200 mM Tris acetate, pH8.1, 100 mM KOAc and
150 mM MgOAc) at 95°C for 35 minutes. Fragmentation
was checked on an agarose gels. Microarrays were hybrid-
ized with 10–12 μg of cRNA in 55 μL in the presence of
40% formamide, 1 mM Tris, 0.1 mM EDTA, 5× SSC and
0.1% SDS for 18 hours at 42°C. Before application to the
array, samples were heated to 95°C for 5 minutes, then at
45°C until ready for hybridization (Max 5–30 minutes).
Hybridization was performed in a MAUI station.
After hybridization, arrays were washed in 0.2% SDS and
0.2× SSC for 2 minutes at 42°C and placed in nonstrin-
gent buffer (6X SSPE, 0.01%{V/V}Tween 20) until ready
for the next wash in 0.2× SSC at room temperature for one
minute. After washing arrays were stained with streptavi-
din-cy3 conjugate from Amersham Pharmacia for 25 min-
utes at room temperature followed by a quick rinse in
0.2× SSC and signals were amplified by antibody amplifi-
cation mix(Antistreptavidin and goat IgG) for 25 minutes.
Staining and amplification was repeated for 10 more min-
utes after a quick rinse in 0.2× SSC. This was followed by
holding the arrays in nonstringent hold buffer until ready
for wash in 0.2× SSC for one minute followed by 30 sec-
onds wash in 0.05× SSC. The arrays were dried with air
duster and were scanned on an Axon 4200B laser scanner
at 5 μm resolution.
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